Perspective Therapeutics (CATX) announced the appointment of Joel Sendek as the Company’s CFO. Sendek previously served as CFO at four biotech companies: Dewpoint Therapeutics, Sema4, Spero Therapeutics, and Forward Pharma. Sendek is succeeding Juan Graham, who will be leaving the Company.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics management to meet with Oppenheimer
- Perspective Therapeutics Appoints Maya Martinez-Davis to Board
- Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
- Perspective Therapeutics Updates on Radiopharmaceutical Advancements
- Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics